changes in the maximal rate of Ca 2+ pump activity (V max ) in any of our genotypes (table S2) . Because DWORF is most abundant in the slow-twitch soleus muscle group, we also measured SERCA activity in soleus homogenates from WT and KO mice and used quadriceps muscles as a control, because DWORF is not expressed in this muscle group. Analysis of homogenates from the soleus muscle of Dworf KO mice revealed a decreased apparent affinity of SERCA for Ca 2+ as compared with homogenates from WT muscles (Fig. 4B  and table S3 ). These differences were not observed in quadriceps muscle (figs. S14B and table S4).
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Mitochondria undergo fragmentation in response to electron transport chain (ETC) poisons and mitochondrial DNA-linked disease mutations, yet how these stimuli mechanistically connect to the mitochondrial fission and fusion machinery is poorly understood. We found that the energy-sensing adenosine monophosphate (AMP)-activated protein kinase (AMPK) is genetically required for cells to undergo rapid mitochondrial fragmentation after treatment with ETC inhibitors. Moreover, direct pharmacological activation of AMPK was sufficient to rapidly promote mitochondrial fragmentation even in the absence of mitochondrial stress. A screen for substrates of AMPK identified mitochondrial fission factor (MFF), a mitochondrial outer-membrane receptor for DRP1, the cytoplasmic guanosine triphosphatase that catalyzes mitochondrial fission. Nonphosphorylatable and phosphomimetic alleles of the AMPK sites in MFF revealed that it is a key effector of AMPK-mediated mitochondrial fission.
M
etabolic stresses that inflict damage to mitochondria trigger mitochondrial fragmentation, leading to degradation of defective mitochondria (mitophagy) or apoptosis in cases of severe damage (1) . This response enables the consolidation of the still-intact functional elements of mitochondria, while allowing for physical segregation of dysfunctional mitochondrial components into depolarized daughter organelles that are targeted for mitophagy (2, 3) . Similarly, proper mitochondrial fission facilitates timely apoptosis (4-7). Mitochondrial fragmentation is also associated with mitochondrial dysfunction, such as in diseases associated with mitochondrial DNA (mtDNA) mutations (8) . Conversely, mitochondrial fusion is thought to promote oxidative phosphorylation (9) , to spare mitochondria from mitophagy (10, 11) , and to allow biodistribution of fatty acids for fuel utilization under nutrient-limited conditions to maintain metabolite pools and efficient adenosine triphosphate (ATP) production (12) .
A central metabolic sensor activated by a wide variety of mitochondrial insults is the adenosine SCIENCE sciencemag.org 15 JANUARY 2016 • VOL 351 ISSUE 6270 monophosphate (AMP)-activated protein kinase (AMPK) (13) . Under conditions when intracellular ATP concentrations decrease, increased intracellular AMP directly binds to the g regulatory subunit of AMPK, facilitating AMPK activation by the upstream protein kinase LKB1. Upon activation, AMPK restores intracellular energy levels through direct phosphorylation of multiple downstream substrates that inhibit ATP-consuming biosynthetic pathways and stimulate catabolic ATPregenerating processes. Because mitochondria supply the majority of cellular ATP, the maintenance of mitochondrial function is critical to maintaining overall energetic homeostasis (14) , but the question of whether AMPK plays direct roles in different aspects of mitochondrial biology has not been well examined. AMPK has previously been tied to mitochondrial integrity through its direct phosphorylation and activation of the highly conserved autophagy kinase ULK1 (Atg1 in yeast) (15, 16) , which promotes mitophagy. In comparison, although mitochondrial fission and fusion rates are known to respond to changes in cellular metabolism, the molecular details of how changes in cellular bioenergetics and nutrients couple to the fission and fusion machinery remain poorly understood (17) . For example, cells treated with mitochondrial inhibitors or bearing mtDNA-linked mutations undergo mitochondrial fragmentation, but much of the biochemical underpinning for these effects remains obscure. Inhibition of mitochondrial fusion due to aberrant processing of Optic atrophy 1 (OPA1, an inner mitochondrial membrane fusion GTPase) is a proposed mechanism (17-21), but it is thought to require a loss of mitochondrial membrane potential, which does not occur with many fragmentationinducing stimuli.
We examined whether AMPK plays a part in the dynamic response of mitochondria to lowered ATP concentrations. To this end, we treated human U2OS osteosarcoma cells with the electron transport chain (ETC) complex I inhibitor rotenone or complex III inhibitor antimycin A for 1 hour and assessed their mitochondrial morphology. Confocal microscopy of endogenous TOM20 staining revealed extensive fragmentation of mitochondria caused by both inhibitors (Fig. 1A , top row). Time-lapse microscopy with MitoTracker dye to visualize live fusion and fission events revealed extensive mitochondrial fragmentation within 30 min after the addition of rotenone (Fig. 1B and movie S1 ). Treatment with either rotenone or antimycin A led to the rapid activation of AMPK and phosphorylation of its well-established downstream substrates acetyl coenzyme A carboxylase (ACC), Raptor, and ULK1 within 15 min (Fig. 1C) .
We next used CRISPR/Cas9 to genetically disrupt the two catalytic subunits of AMPK (AMPKa1 and AMPKa2) in U2OS cells (AMPK double knockout, DKO) ( fig. S1A ). We demonstrated that both AMPK catalytic subunits must be genetically removed in U2OS cells to fully abolish AMPK signaling in this cell type (Fig. 1C and fig. S1B ), similar to what is observed in other cell types (22) . In AMPK DKO U2OS cells, the effect of rotenone or antimycin A on mitochondrial fragmentation was significantly attenuated (Fig. 1, A and  D) , as visualized by TOM20 staining at fixed time points (Fig. 1A) and by time-lapse microscopy ( Fig.  1B and movie S2), despite comparable effects on oxygen consumption rates ( fig. S1C ). Lentivirus was used to stably reconstitute a wild-type AMPKa1 or AMPKa2 cDNA into the AMPK DKO U2OS cells to confirm that the loss of mitochondrial fragmentation was not an artifact of the chosen AMPK DKO clone. In cells treated with rotenone and antimycin A, either reconstituted AMPKa1 or AMPKa2 was sufficient to restore mitochondrial fragmentation and phosphorylation of downstream substrates, suggesting that either of the a subunits is capable of mediating these responses in U2OS cells (Fig. 1, A and D, and  fig. S1D ).
Some stimuli that acutely trigger mitochondrial fragmentation lead to proteolytic cleavage and inactivation of the OPA1 GTPase that mediates inner mitochondrial membrane fusion (17) (18) (19) (20) (21) . We therefore compared the induction of AMPK activation with the induction of OPA1 proteolytic cleavage. Although the ETC uncoupler CCCP (carbonyl cyanide m-chlorophenyl hydrazone) promoted OPA1 processing, this effect was absent in cells treated with rotenone or antimycin A (fig. S1E), supporting reports that a loss of mitochondrial membrane potential is required for OPA1 cleavage (17) (18) (19) (20) . Immunoblotting of wild-type and AMPK DKO cells after CCCP treatment revealed that OPA1 cleavage was independent of AMPK status, reinforcing that these are two independent biochemical events. AMPK is activated by a loss of ATP due to ETC inhibition, whereas OPA1 cleavage is induced only after the more extensive mitochondrial damage that accompanies a loss of mitochondrial membrane potential.
We next examined whether direct pharmacological activation of AMPK in the absence of mitochondrial inhibitor treatment would be sufficient to induce mitochondrial fission. The small molecule A769662 and related compounds (MT63-78 and 991) were isolated from high throughput screens for AMPK activators (23) (24) (25) . All of the A769662-related compounds are thought to bind in a cleft between the AMPK a and b subunits, in contrast to AMP-mimetic compounds such as AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), which bind to nucleotide binding pockets in AMPKg subunits to trigger activation of AMPK kinase complexes (26) . Treatment of U2OS cells with A769662 for 1 hour resulted in mitochondrial fragmentation equivalent to that which occurred after rotenone or antimycin A treatment (compare Fig. 2 , A to C, with Fig. 1 , A, B, and D). This effect was almost fully ablated in the AMPK DKO U2OS cells (Fig. 2, A and B, and fig. S2A ). Similarly, the cell-permeable AMPmimetic AICAR increased the percentage of cells with short mitochondria, an effect ablated in the AMPK DKO U2OS cells (Fig. 2, A and B) . The effects of these two mechanistically distinct direct AMPK activators on mitochondrial fragmentation were restored in the AMPK DKO U2OS cells that were stably reconstituted with either wild-type AMPKa1 or AMPKa2 cDNAs (Fig. 2,  A and B) , which also restored full downstream AMPK signaling ( fig. S2B) .
We also assessed AMPK induction of mitochondrial fragmentation in SV40-immortalized murine embryonic fibroblasts (MEFs) bearing floxed alleles of AMPKa1 (Prkaa1) and AMPKa2 (Prkaa2) that we derived de novo from embryonic day-13 mouse embryos to ensure equivalent starting mitochondrial populations. These cells were transduced with adenoviruses bearing either the Cre recombinase or the FlpO recombinase to obtain parallel treated cultures in which both AMPKa1 and AMPKa2 were deleted or that were exposed to a nontargeting control recombinase, respectively. Immunoblotting confirmed efficient deletion of AMPKa1 and AMPKa2 and a loss of downstream signaling only in the Cretreated cells ( fig. S2C ). Mitochondrial networks in MEFs are shorter and less tubulated under basal conditions compared with those in U2OS cells, but treatment with rotenone further induced fragmentation of mitochondria in wild-type MEFs, which was largely ablated in the AMPK DKO MEFs (Fig. 2, D and E). Direct activation of AMPK with MT63-78 (a more potent A769662 derivative) (25) induced acute mitochondrial fragmentation in MEFs to an extent comparable to that with rotenone treatment, which was also attenuated in the AMPK DKO MEFs (Fig. 2,  D and E). The observation that mechanistically distinct AMPK activators can consistently induce fragmentation to the same extent as ETC inhibitors, across cell types with morphometrically distinct mitochondrial networks, suggests that AMPK may directly regulate some component (s) of the mitochondrial fission and fusion machinery to mediate these events.
Previously, our laboratory has used proteomic and bioinformatics approaches to identify AMPK substrates (15, (27) (28) (29) . In one screen for AMPK substrates, we identified a protein named C2orf33, which subsequently was renamed mitochondrial fission factor (MFF). MFF is a mitochondrial outermembrane protein that was discovered in an RNA interference screen aimed at identifying factors required for mitochondrial fission (30) . Mitochondrial fission involves the recruitment of the GTPase dynamin-related protein 1 (DRP1) from the cytosol to the mitochondrial surface to catalyze the fission reaction. Genetic analysis has demonstrated that MFF is the dominant receptor for DRP1 in most mammalian cell types examined to date (31) (32) (33) . MFF contains two predicted candidate AMPK phosphorylation sites, Ser 155 and Ser 172 in human MFF, which lie between the DRP1-interacting region at the amino terminus and the mitochondrial targeting transmembrane domain at the carboxyl terminus (Fig. 3A and fig. S3A ). MFF was directly phosphorylated by recombinant AMPK, and, although mutation of Ser 172 attenuated most of the in vitro phosphorylation, it was only fully ablated when Ser 155 was also mutated (Fig. 3B) . We used phosphomotif antibodies directed against the AMPK optimal substrate motif (27) or the optimal 14-3-3 binding motif to determine whether they recognize MFF phosphorylated at Ser 155 or Ser 172 in vivo. FLAGtagged variants of MFF cDNAs were stably introduced into wild-type MEFs, and treatment of the cells with AICAR increased MFF phosphorylation (Fig. 3C) . A nonphosphorylatable Ser172Ala mutation abolished interaction with the antibody to the 14-3-3 binding motif, whereas a nonphosphorylatable Ser155Ala mutation abolished the interaction with the antibody to the AMPK substrate motif, and mutation of either site alone did not affect the AICAR-induced phosphorylation of the other site (Fig. 3C) . Phosphorylation of either site was largely ablated in the AMPK DKO MEFs (Fig. 3D) .
SCIENCE sciencemag.org 15 To examine endogenous MFF phosphorylation, we developed a phosphospecific antibody to phospho-Ser 172 (P-Ser 172 ), which we validated for phosphospecificity and induction in cells either expressing an activated allele of AMPK or treated with metabolic stress (fig. S3, B and C (fig. S4B) . Next, we immunoblotted parallel lysates from AMPK wild-type and genetically matched DKO MEFs treated with rotenone or MT63-78, in which AMPK was critical for mitochondrial shortening (Fig. 2, D mitochondrial fragmentation and phosphorylation of other AMPK substrates (Fig. 3E) . Mitochondrial morphology is altered in hepatocytes upon genetic deletion of AMPK (15); we therefore also examined MFF in this cell type. AICAR treatment of primary hepatocytes induced phosphorylation of endogenous MFF Ser 172 and other AMPK substrates ( fig. S4D ). Another mitochondrial inhibitor that activates AMPK is metformin, the most-widely prescribed type 2 diabetes drug in the United States and worldwide (2) . Metformin treatment of hepatocytes resulted in phosphorylation of endogenous MFF Ser 172 in a dose-and time-dependent manner, paralleling AMPK phosphorylation of Raptor and ULK1-effects which were abolished in AMPK DKO hepatocytes (Fig. 3F) .
To test the effects of AMPK phosphorylation on MFF function, we first used MEFs that we have previously reported as lacking most functional DRP1 receptors [Mff
, and Mid51 short hairpin-mediated RNA interference (shRNA), referred to as 3KD MEFs] ( fig.  S5A) (31) . Mitochondrial shortening that was induced by AICAR in wild-type cells was abolished in the 3KD cells (fig. S5B) . Reconstitution of the 3KD cells with wild-type MFF cDNA demonstrated that MFF expression alone was sufficient to restore mitochondrial fragmentation in response to AICAR (fig. S5C ). Subsequent analysis of MEFs that were genetically disrupted only for MFF (Mff −/− ) revealed they were also completely defective for AICAR-induced fragmentation ( fig. S5D ).
As the major receptor for DRP1, MFF is required for steady-state localization of DRP1 to the mitochondria (31, 33) . Reconstitution of the 3KD MEFs with a wild-type MFF cDNA revealed a much greater colocalization of endogenous DRP1 to the mitochondria when MFF expression was restored, as compared with the control vector (Fig. 4, A and B) . Treatment of cells with AICAR further increased colocalization of endogenous DRP1 with TOM20 in 3KD MEFs reconstituted with wild-type MFF, but this treatment failed to do so in the luciferase control 3KD MEFs (Fig. 4, A and B) . This increase in DRP1 and TOM20 colocalization was attenuated in the cells stably expressing nonphosphorylatable Ser155Ala-Ser172Ala (SA2) mutant MFF, though amounts of MFF and DRP1 were comparable across these stable cell lines ( fig. S5E ). Similar effects on DRP1 and TOM20 colocalization were observed in response to rotenone treatment in cells bearing wild-type versus SA2 MFF (Fig. 4C and fig. S5F ). These data indicate that basal DRP1 localization to mitochondria is largely normal in the SA2 cells but that AICAR and rotenone induce acute recruitment of DRP1 to the mitochondria, and this effect is abolished when AMPK cannot phosphorylate Ser 155 and Ser 172 in MFF. To model the effects of AMPK phosphorylation, we created phosphomimetic Ser155Asp-Ser172Asp (SD2) and Ser155Glu-Ser172Glu (SE2) mutants. Despite being expressed at equal levels to wildtype MFF protein ( fig. S6A ), both the SD2 and SE2 MFF mutants displayed gain-of-function activity when introduced into 3KD or Mff −/− MEFs, resulting in shortened mitochondria even in the absence of stimuli, comparable to those induced by AICAR in cells expressing wild-type MFF ( fig. S6, B to E) . Moreover, neither AICAR nor MT63-78 treatment further shortened the mitochondria in SD2-and SE2-expressing cells ( fig. S6, C to E) . Fragmented mitochondria are correlated with increased production of reactive oxygen species (35) . Consistent with this, among all the 3KD cell lines, SD2-and SE2-MFF expressing cells exhibited the greatest accumulation of reactive oxygen species after rotenone treatment ( fig. S6F) .
To examine the function of the AMPK-dependent phosphorylation of MFF in vivo, in a cell type in which the AMPK pathway plays critical roles and in which mitochondrial homeostasis is paramount (36, 37), we expressed wild-type, SA2, or SD2 MFF cDNAs in layer 2/3 cortical pyramidal neurons using in utero cortical electroporation (36) . Co-electroporation of cDNAs encoding myristoylated (m)Venus and mt-DsRed enabled quantitative imaging of mitochondrial morphology in dendritic segments of single neurons 3 weeks after birth (fig. S7, A and B) . In control neurons, mitochondria morphology in the dendrites of pyramidal neurons is elongated (Fig. 4D) . In contrast, enforced equivalent expression of wildtype or SD2 but not SA2 MFF resulted in fragmented mitochondria in the dendrites (Fig. 4, D and E). All three forms of MFF (wild-type, SA2, and SD2) were targeted to mitochondria and expressed at similar levels ( Fig. 4F and fig. S7C ). These results indicate that MFF is sufficient to induce fragmentation of neuronal mitochondria in vivo and that this effect requires phosphorylation of Ser 155/172 . AMPK is rapidly activated by mitochondrial stress and acutely triggers mitochondrial fission, at least in part via phosphorylation of MFF. This rapid AMPK-dependent induction of mitochondrial fission may serve as one way for the cell to prepare to initiate mitophagy of those mitochondrial fragments that have extensive damage (38) . Though AMPK is a highly conserved sensor of mitochondrial damage across eukaryotes, MFF is one of the first AMPK substrates to have been discovered to directly control mitochondrial biology. AMPK is also known to induce mitochondrial biogenesis in various tissues (13) , and AMPK directly phosphorylates and activates the first component of the autophagy cascade, the kinase ULK1 (15) . Thus, AMPK emerges as a master regulator of mitochondrial homeostasis, coupling fission to mitophagy and, after prolonged energy stress, signaling the nucleus to initiate biogenesis of new mitochondria to replace the damaged ones.
